Lenzing's Numbers Are Improving — But the Market Is Still Weighing the Cost of Its Own Medicine
Published on 09/09/2026 at 15:44 | Editorial boerse-global.de
The Austrian fiber group Lenzing has posted a first-half net profit of €35.6 million, more than double the €15.2 million it earned in the same period a year earlier. EBITDA came in at €239.2 million on revenue of €1.27 billion, while free cash flow climbed to €45.8 million. The results, published on August 5, suggest the underlying business is holding up even as the company dismantles parts of itself.
Investors, however, have yet to be won over. The shares closed at €22.60 on Tuesday, down 1.3 percent on the day, and have shed 4.2 percent over the past month. The stock now trades roughly 5.4 percent below its 50-day moving average of €23.88 and remains 24 percent adrift of its 52-week high of €29.75. Since the start of the year, the equity is down 2.8 percent.
A turnaround that demands money and sacrifice in equal measure
The improved earnings arrive alongside a sweeping strategic overhaul unveiled in late July under the banner "Grow Nonwovens, Reset Textiles." The plan calls for organic expansion in the nonwovens business, a sharper focus on premium segments in textiles, and reinforcement of the pulp and biorefinery operations. But the repositioning comes at a heavy price: fiber production in Heiligenkreuz in Burgenland will cease by the end of this year, the Grimsby site in England follows by the end of 2027, and roughly 2,000 jobs are slated to go group-wide by end-2027. Since that announcement just over six weeks ago, the stock has lost around 3.4 percent.
The financial drag is visible in the accounts. Lenzing expects impairment charges on property, plant and equipment of up to €150 million for 2026 — a hit to EBIT and group net income, though not to EBITDA. Restructuring provisions for personnel measures of up to €40 million will, by contrast, flow directly into this year's EBITDA.
Major restructuring brings plant closures, job cuts and unfamiliar risks on the shop floor. When operations change this quickly, safety documentation often lags behind reality. A free toolkit with 41 ready-to-use templates and checklists helps you keep risk assessments current through periods of transition. Download the free Risk Assessment Toolkit
The €600 million question
The market's caution is understandable given what lies ahead. An extraordinary general meeting held just yesterday approved a capital increase of around €300 million, with subscription rights for existing shareholders preserved. Combined with additional debt financing of €300 million, Lenzing has secured a total war chest of €600 million. The capital raise must be completed by February 25, 2027 — a tight window for an operation of this size.
The timing is awkward. Lenzing is asking shareholders to stump up fresh equity at the precise moment it is closing plants and cutting thousands of jobs. A rights issue of this magnitude will dilute existing holdings noticeably, and there is no guarantee that investors will line up enthusiastically for a company in the middle of a painful contraction. Should subscription demand fall short, Lenzing could be forced to accept less favorable terms or lean more heavily on the debt component already earmarked.
Late July also brought new financing agreements of up to €300 million and extensions of existing debt maturities out to 2030, providing some breathing room on the liability side.
New leadership, new oversight
The governance layer is shifting in tandem. Georg Kasperkovitz took over as chief executive on June 1 under a three-year contract running to the end of May 2029, stepping in at a moment when the company is executing its most significant restructuring in years. The extraordinary general meeting also installed Martin Seiter as a new supervisory board member, succeeding Franz Gasselsberger, who stepped down at his own request. The board refresh signals that control functions are being recalibrated even as management drives the operational overhaul.
Kasperkovitz has indicated he is seeking a new owner for the Heiligenkreuz site, noting that a sale process could "experience-wise" be concluded within a few months.
What to watch
The central test in the months ahead is not the leadership change itself but whether the rights issue goes through smoothly and on acceptable terms. If existing shareholders subscribe in sufficient numbers, the balance sheet gets reinforced just as the costly plant closures in Burgenland and England begin to bite. That would give Kasperkovitz room to demonstrate early in his tenure that a leaner, more focused Lenzing can emerge from the upheaval.
The bearish counter-scenario is equally clear: weak subscription demand would jeopardize the February 2027 deadline and pile more pressure on the debt financing. A new CEO juggling a capital raise, factory shutdowns, job cuts and a strategic pivot all at once leaves little margin for error. Delays in any one area could cascade into the others and erode confidence in the new leadership team's ability to deliver.
There are some encouraging operational signs. Lenzing took on 38 new apprentices in September, a signal that it continues to invest at core sites despite the restructuring. And the first-half profit suggests the operating engine can carry the weight of the transformation without stalling.
For now, the picture is one of an orderly if painful transition — provided the capital increase progresses on schedule and the plant closures proceed without major disruption. The next concrete checkpoints are the pace of the rights issue in the coming months and the speed with which the Burgenland shutdown is completed by year-end. Only when both show tangible progress will it become clear whether the new leadership marks a genuine turning point or merely the beginning of a longer, harder grind.
